Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free Survival

D.j. Noble, E. Doyle, G. Tramonti, A.b. Law, A. Sundaramurthy, J.p. Brush, J. Keanie, C. Wood, P. Drewell, W. Keough, D.b. Mclaren*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalClinical Oncology
Publication statusPublished - 28 Nov 2021

Cite this